Keros Therapeutics, Inc. (KROS) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $2.30 | +146.0% |
| 2024 | $-5.00 | +3.8% |
| 2023 | $-5.20 | -25.3% |
| 2022 | $-4.15 | -64.7% |
| 2021 | $-2.52 | +14.0% |
| 2020 | $-2.93 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $2.30 | +146.0% |
| 2024 | $-5.00 | +3.8% |
| 2023 | $-5.20 | -25.3% |
| 2022 | $-4.15 | -64.7% |
| 2021 | $-2.52 | +14.0% |
| 2020 | $-2.93 | — |